Dynamics of abdominal symptoms during the start of a new therapy with Elexacaftor/Tezacaftor/Ivacaftor using the novel CFAbd-day2day questionnaire

Jochen G. Mainz; Anton Barucha; Pu Huang; Lilith Bechinger; Franziska Duckstein; Louise Polte; Pauline Sadrieh; Lutz Nährlich; Olaf Eickmeier; Suzanne van Dullemen; Patience Eschenhagen; Carsten Schwarz; Stefan Lüth; Carlos Zagoya; Ute Graepler-Mainka

doi:10.1101/2023.07.31.23293088

Dynamics of abdominal symptoms during the start of a new therapy with Elexacaftor/Tezacaftor/Ivacaftor using the novel CFAbd-day2day questionnaire

Jochen G. Mainz, Anton Barucha, Pu Huang, Lilith Bechinger, Franziska Duckstein, Louise Polte, Pauline Sadrieh, Lutz Nährlich, Olaf Eickmeier, Suzanne van Dullemen, Patience Eschenhagen, Carsten Schwarz, Stefan Lüth, Carlos Zagoya, Ute Graepler-Mainka

doi: https://doi.org/10.1101/2023.07.31.23293088

Jochen G. Mainz

1CF-Center, Klinikum Westbrandenburg, Campus Brandenburg an der Havel, Germany

2Medizinische Hochschule Brandenburg (MHB), Universitätsklinikum, Brandenburg an der Havel, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: j.mainz@klinikum-brandenburg.de

Anton Barucha

1CF-Center, Klinikum Westbrandenburg, Campus Brandenburg an der Havel, Germany

2Medizinische Hochschule Brandenburg (MHB), Universitätsklinikum, Brandenburg an der Havel, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Pu Huang

1CF-Center, Klinikum Westbrandenburg, Campus Brandenburg an der Havel, Germany

2Medizinische Hochschule Brandenburg (MHB), Universitätsklinikum, Brandenburg an der Havel, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Lilith Bechinger

1CF-Center, Klinikum Westbrandenburg, Campus Brandenburg an der Havel, Germany

2Medizinische Hochschule Brandenburg (MHB), Universitätsklinikum, Brandenburg an der Havel, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Franziska Duckstein

1CF-Center, Klinikum Westbrandenburg, Campus Brandenburg an der Havel, Germany

2Medizinische Hochschule Brandenburg (MHB), Universitätsklinikum, Brandenburg an der Havel, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Louise Polte

1CF-Center, Klinikum Westbrandenburg, Campus Brandenburg an der Havel, Germany

2Medizinische Hochschule Brandenburg (MHB), Universitätsklinikum, Brandenburg an der Havel, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Pauline Sadrieh

1CF-Center, Klinikum Westbrandenburg, Campus Brandenburg an der Havel, Germany

2Medizinische Hochschule Brandenburg (MHB), Universitätsklinikum, Brandenburg an der Havel, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Lutz Nährlich

3CF Center for Children Justus-Liebig-Universität Gießen, Universitätsklinikum Gießen-Marburg GmbH, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Olaf Eickmeier

4Division of Allergy, Pulmonology and Cystic Fibrosis, Department for Children and Adolescents, University Hospital, Frankfurt, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Suzanne van Dullemen

4Division of Allergy, Pulmonology and Cystic Fibrosis, Department for Children and Adolescents, University Hospital, Frankfurt, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Patience Eschenhagen

5CF-Center, Klinikum Westbrandenburg, Campus Potsdam, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Carsten Schwarz

5CF-Center, Klinikum Westbrandenburg, Campus Potsdam, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Stefan Lüth

6Department of Gastroenterology, Brandenburg Medical School (Theodor Fontane), Brandenburg an der Havel, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Carlos Zagoya

1CF-Center, Klinikum Westbrandenburg, Campus Brandenburg an der Havel, Germany

2Medizinische Hochschule Brandenburg (MHB), Universitätsklinikum, Brandenburg an der Havel, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ute Graepler-Mainka

7Children’s Hospital, Eberhard-Karls-University, Tübingen, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Abstract
Full Text
Info/History
Metrics
Data/Code
Preview PDF

8 Data Availability Statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation

View the discussion thread.

PreviousNext

Posted August 02, 2023.

Download PDF

Data/Code

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Dynamics of abdominal symptoms during the start of a new therapy with Elexacaftor/Tezacaftor/Ivacaftor using the novel CFAbd-day2day questionnaire

Message Subject (Your Name) has forwarded a page to you from medRxiv

Message Body (Your Name) thought you would like to see this page from the medRxiv website.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Dynamics of abdominal symptoms during the start of a new therapy with Elexacaftor/Tezacaftor/Ivacaftor using the novel CFAbd-day2day questionnaire

medRxiv 2023.07.31.23293088; doi: https://doi.org/10.1101/2023.07.31.23293088

Share This Article:

Citation Tools

Dynamics of abdominal symptoms during the start of a new therapy with Elexacaftor/Tezacaftor/Ivacaftor using the novel CFAbd-day2day questionnaire

medRxiv 2023.07.31.23293088; doi: https://doi.org/10.1101/2023.07.31.23293088

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Tweet Widget
Facebook Like
Google Plus One

Subject Area

Respiratory Medicine

Subject Areas

All Articles

Addiction Medicine (399)
Allergy and Immunology (708)
Anesthesia (201)
Cardiovascular Medicine (2936)
Dentistry and Oral Medicine (333)
Dermatology (249)
Emergency Medicine (439)
Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1035)
Epidemiology (12741)
Forensic Medicine (12)
Gastroenterology (827)
Genetic and Genomic Medicine (4581)
Geriatric Medicine (417)
Health Economics (729)
Health Informatics (2914)
Health Policy (1069)
Health Systems and Quality Improvement (1077)
Hematology (388)
HIV/AIDS (924)
Infectious Diseases (except HIV/AIDS) (14097)
Intensive Care and Critical Care Medicine (846)
Medical Education (425)
Medical Ethics (115)
Nephrology (468)
Neurology (4348)
Nursing (236)
Nutrition (638)
Obstetrics and Gynecology (803)
Occupational and Environmental Health (734)
Oncology (2268)
Ophthalmology (646)
Orthopedics (258)
Otolaryngology (324)
Pain Medicine (279)
Palliative Medicine (83)
Pathology (501)
Pediatrics (1196)
Pharmacology and Therapeutics (504)
Primary Care Research (496)
Psychiatry and Clinical Psychology (3752)
Public and Global Health (6934)
Radiology and Imaging (1527)
Rehabilitation Medicine and Physical Therapy (902)
Respiratory Medicine (915)
Rheumatology (437)
Sexual and Reproductive Health (443)
Sports Medicine (385)
Surgery (487)
Toxicology (60)
Transplantation (210)
Urology (180)